insider trading mkt manip
20 disambig, includes MoC
see stock act trade
SEE PREDICTIVE POLYMKT
see TRUMP DELL INTEL APL
---
---
-=-=
an 9 26
Morning Joe aghast Trump is trading more stocks than all of Congress
-=-=
-=-=-
dck 11 26
Search Assist
Brandon Lutnick, son of Commerce Secretary Howard Lutnick, is the chairman of Cantor Fitzgerald, which has been involved in buying rights to tariff refunds from U.S. companies, potentially profiting from the Supreme Court's decision to strike down tariffs. This situation has raised concerns about conflicts of interest and insider trading due to the Lutnick family's close ties to the Trump administration.
Involvement of Brandon Lutnick in Tariff Refunds
Background
Brandon Lutnick is the son of Commerce Secretary Howard Lutnick and currently serves as the chairman of Cantor Fitzgerald. The firm has been implicated in purchasing rights to tariff refunds from U.S. companies, which has raised significant ethical concerns.
Key Points
- Tariff Refund Market: Cantor Fitzgerald has engaged in buying rights to tariff refunds, offering companies a fraction of what they paid in tariffs in exchange for the full refund amount if the tariffs were deemed illegal.
- Supreme Court Ruling: The Supreme Court recently struck down tariffs imposed under the Trump administration, potentially allowing for substantial refunds to U.S. firms. This ruling has created a secondary market for these refunds, which Cantor Fitzgerald is positioned to profit from.
- Conflict of Interest Concerns: The close relationship between the Lutnick family and the Trump administration has led to allegations of insider trading and conflicts of interest. Critics, including Rep. Jamie Raskin, have called for investigations into whether Cantor Fitzgerald had access to nonpublic information that influenced their trading decisions.
Potential Financial Impact
| Aspect | Details |
|---|---|
| Estimated Refunds | Up to $180 billion in potential refunds |
| Cantor Fitzgerald's Offer | 20-30% of the tariff amount for refund rights |
| Example Transaction | A company paying $10 million could receive $2-3 million in a trade |
The situation surrounding Brandon Lutnick and Cantor Fitzgerald highlights significant ethical questions regarding the intersection of government policy and private financial gain.
Newsweek
Howard Lutnick's Son Under Investigation Over Alleged Tariff Ruling ...
Feb 27, 2026Rep. Jamie Raskin sent a letter to Commerce Secretary Howard Lutnick and his son Brandon, citing potential conflicts of interest.
---
AN 5 26
President Donald Trump has been engaged in a historic and ruthless level of corruption since his return to the White House last year, and according to numerous ethics experts who spoke with The New Yorker, it will require a level of reform amounting to "radical surgery" in order to prevent future presidents from doing the same thing.
In a piece published Monday, New Yorker staff writer John Cassidy laid out the ever-expanding scope of Trump's corruption in office, including his trading of stocks for companies with business before the U.S. government and, most damningly, his new $1.8 billion DOJ slush fund that would essentially loot the U.S. Treasury of taxpayer funds to line the pockets of the president and his allies.
For the report, Cassidy spoke with Richard Painter, a law professor at the University of Minnesota who also served as the chief ethics lawyer in the White House under George W. Bush, where he notably halted the hiring of a Goldman Sachs executive as Treasury Secretary, due to the conflict-of-interest laws their appointment would violate. When pressed about the current situation with Trump, Painter said that historical parallels were inadequate.
"[Former President Richard] Nixon had his issues, but I don’t think there is anything like this,” Painter said. “The President is specifically precluded from getting any financial favors from the Treasury while in office.”
Cassidy spoke with a variety of other experts in addition to Painter about what sorts of things would need to be done in order to protect the country from having to weather the corruption of a future president similar to Trump, and the answers suggested that vast, sweeping ethics reforms are in order.
"Painter told me that the first task is to make the President and Vice-President subject to the federal conflict-of-interest law, and require them to divest their conflictive assets," Cassidy detailed. "Another obvious and necessary reform is a ban on trading individual stocks, one that applies to Presidents and members of Congress alike."
Passing such a reform would require action from Congress that appears unlikely with Republicans in the majority. The alternative would be to impeach presidents who violate the rules against self-enrichment by the Executive Branch, but as Painter noted, "We already tried that twice and failed."
"Ultimately, then, it comes back to politics, where there are structural problems that run even deeper than Trump," Cassidy added. "In the post-Citizens United world, Presidents—Republican and Democrat alike—sit atop political parties and allied fund-raising entities that can gin up practically unlimited sums, which can be used to crush dissidents. (This month, in Kentucky, Representative Thomas Massie, a Republican willing to criticize Trump, was defeated in what became the most costly House primary on record.) The weight of money shifts the balance of power away from individual members of Congress, insuring that for many of them the default position is submission."
He continued: "What we’ve learned during the past decade is that when the Supreme Court puts democracy up for sale, Congress is utterly beholden to a President, and if that President is a malign actor, the U.S. Constitution is no longer fit for purpose. Trump is ruthlessly exploiting this weakness, but he didn’t create it. Assuming that the Republic does eventually get past him and his grifting, it will need radical surgery, not merely a reset."
---
AN 5 26
Trump insider trading should prompt 'extensive criminal prosecutions': expert - Alternet.org
// RWW
05/18/2026
by
- Alex Nguyen @ Mother Jones: Trump Just Gave Himself a $1.8 Billion Slush Fund to Reward His Friends
And the public may never know who their money was spent on.
- Jon Wertheim, Aliza Chasan, Andrew Bast, and Jessica Kegu @ CBS News: Suspected insider accounts net $2.4 million on Polymarket Iran war bets with 98% win rate, firm finds
Nine connected Polymarket accounts have raked in more than $2.4 million betting almost exclusively on U.S. military actions in what digital detectives from the data analytics firm Bubblemaps have identified as a potentially egregious case of insider trading.
---
AN 5 26
President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs, as the agencies he oversees undertook an agenda that largely benefited the company.
On May 14, the federal government released ethics disclosures revealing a list of stock and bond trades made on Trump’s behalf from January to March of this year. They included extensive trades across the economy, including investments in tech giants such as Microsoft and Nvidia, aerospace firms such as Boeing, and household-name companies such as Target and Chipotle.
In healthcare, however, the trades for Lilly — a company valued by the stock market at just under $1 trillion — stand out. That’s because the timing of Trump’s purchases coincides with several favorable government decisions benefiting the drugmaker’s GLP-1 business, including progress toward a long-held goal: qualifying the drugs for reimbursement from Medicare, the government health insurance program primarily serving seniors, when they are prescribed for weight loss.
The disclosure forms — which bear Trump’s distinct signature — give ranges rather than exact dollar amounts for the trades. They show seven purchases of Lilly stock made on the president’s behalf through the end of March, the first of which occurred on Jan. 6.
During that period, and just afterward, several Trump administration initiatives ultimately benefited Lilly. Perhaps the biggest was an initiative from the Centers for Medicare & Medicaid Services, which was proposing a pilot program — a temporary “bridge,” potentially followed by permanent reimbursement — through which Medicare patients would pay $50 a month for GLP-1 drugs.
The deadline for drug manufacturers to submit applications indicating their interest in participating was Jan. 8. Lilly has since been named as a participating manufacturer in the program, calling it a “significant milestone.”
Another purchase on Feb. 10, of West Pharmaceutical Services stock valued between $250,000 and $500,000, was similarly a bet on the GLP-1 market. The company, which manufactures injectable devices for drugs, credited growth in its GLP-1 business with driving increased revenue in its most recent quarter.
Lilly declined to comment. West Pharmaceutical Services did not immediately respond to a request for comment.
A spokesperson at the Department of Health and Human Services declined to comment, referring KFF Health News to the White House. A White House spokesperson referred questions to the Trump Organization — the holding company for most of the president’s businesses — which did not immediately respond to a request for comment.
In response to other outlets’ questions about Trump’s stock trades, the Trump Organization has said the investments are controlled by independent brokers.
It is unclear from the disclosures whether Trump directed any of the trades himself. Four of the Lilly stock purchases are marked “unsolicited,” though the Office for Government Ethics did not immediately respond to a request for clarification on the use of that term.
Trump’s assets are in a trust held by his children, and Trump Organization spokespeople have said in the past that neither the president nor his children play a role in “selecting, directing, or approving” specific investments.
Eric Trump, the president’s son and a Trump Organization executive, said May 15 on X: “To suggest that individual stocks are being bought or sold, at the discretion of any member of the Trump family, would be a lie and blatantly false.”
He claimed the purchases of index funds account for the investments. The disclosures record purchases of funds and individual stocks.
Lilly had a strong 2025, finishing with $65 billion in revenue, up $20 billion from the year before. GLP-1 drugs accounted for a substantial portion of that total.
At the beginning of 2026, the drugmaker said it expected another surge in revenue this year, above $80 billion. It was a “stunning” projection, analysts at the bank Citi said.
Analysts for the financial services firm TD Cowen said the Medicare and Medicaid market would be critical to making it happen. “Guidance anticipates favorable impact from Medicare coverage of obesity medications by 7/1/26,” the analysts noted.
Historically, Medicare hasn’t covered obesity drugs. In a May 2025 open letter, noting unfavorable reimbursement decisions across government and private-run insurance, Lilly said: “This isn't about just one medicine, formulary, or insurance plan. It’s about a system that limits patients’ and health care providers’ ability to choose an obesity management treatment plan that is best for them.”
Key to that market was the pilot program rolled out by CMS, called BALANCE, aimed at helping Medicare and Medicaid beneficiaries improve their health. Last fall, 12% of U.S. adults reported currently using GLP-1s, according to a KFF poll, and 56% of those who had used GLP-1s found the medications — prescribed to treat diabetes and aid weight loss — hard to afford.
The appearance of a potential conflict of interest is enough to trouble ethics experts.
“A president who buys or sells the stock of a company whose value is affected by his administration’s actions undermines the public’s trust in two ways,” said Kathleen Clark, a legal ethicist at Washington University in St. Louis.
First, she said, the public should believe government actions are motivated by common good, not personal enrichment. And second, the public should believe that those within government aren’t benefiting from inside information.
A ban on stock trading by the president would require an act of Congress, though some lawmakers have resisted such legislation. Members of Congress are also permitted to buy and sell stocks.
Trump’s White House and HHS boosted GLP-1s throughout the first few months of the year. In February, the government unveiled TrumpRx, a web portal directing patients to lower-price versions of some drugs, with some terms and conditions.
The website offers Zepbound for as low as $299 a month and points patients to LillyDirect, the drug company’s telemedicine service prescribing the drug. Company executives haven’t commented on TrumpRx specifically, but they have touted the telemedicine service. Lilly’s 2025 annual filing to the Securities and Exchange Commission said LillyDirect was a “growing portion of our business.”
Also, in February the FDA intensified a broad crackdown on “compounded” GLP-1s — drugs manufactured by pharmacies that are cheaper and, critics charge, often unsafe alternatives to Lilly’s branded products.
The agency made another favorable decision for Lilly in April, approving its Foundayo weight loss pill under its Commissioner’s National Priority Voucher program. The program was launched by FDA Commissioner Marty Makary, who had promised to approve high-priority drugs in record time. Foundayo was approved in 50 days after filing.
“This approval demonstrates what the FDA can achieve when we eliminate delays and prioritize fast and thorough work from the agency and industry partners,” Makary, who stepped down last week, said in an April news release.
Not all agency decisions were favorable. The FDA asked Lilly to provide additional safety data regarding liver toxicity in Foundayo, though analysts don’t appear particularly troubled. The company has told news outlets that no negative safety signals have been observed.
---
AN 5 26
Journalist painstakingly details 3 'smoking guns' in Trump’s stock disclosure - Alternet.org
TRUMP SECRET STOCK TRADING INCL APPLE
Jim Cramer becomes totally incoherent trying to explain away Trump’s insider trading - Alternet.org 5 26
---
---
an 3 26
Conservative Dispatch CEO and editor Steve Hayes visited Bonita Springs, Florida, during campaign season and says he found the kind of political personalities you get in “Trump country.”
Former U.S. Rep. Madison Cawthorn was one of the first personalities Heyes shined a light on trying to nab Florida’s 19th Congressional District. In his article, titled “Meet the Has-Beens, Never-Weres, and Felon Locked in a Trumpy Primary,” he makes clear he is not impressed.
“That Cawthorn is a viable candidate — indeed, given his name recognition and MAGAworld celebrity status, he’s considered a real contender—says a lot about the contest in this dark red corner of Florida’s Gulf Coast and about the state of the Republican Party in the Trump era,” said Hayes, recounting Cawthorn’s congressional service beginning “with a rousing speech to the pro-Trump mob at the U.S. Capitol on January 6, 2021,” where he praised the mob’s “willingness to fight, declared the 2020 election fraudulent, and later voted against certification.”
But that same career ended with “a flurry of bizarre and discrediting moments over the weeks leading up to the GOP primary for his reelection campaign,” said Hayes.
“A week after he lost that primary contest, the House Ethics Committee announced it was investigating the congressman for a possible improper relationship with a staffer and for a potential conflict of interest in his promotion of the LGB (Let’s Go Brandon) cryptocurrency,” for which he was ultimately fined $15,000,” said Hayes.
Another Trump Republican with a legal background would be former New York U.S. Rep. Chris Collins, who was charged with lying to the FBI in 2018, on top of charges related to insider trading. Republican leaders stripped Collins of his committee assignments. And even though he initially insisted on his innocence, two months later he accepted a plea deal. Three months after that he confessed his guilt at his sentencing hearing.
“Jonathan Barr, another lawyer for Collins, told Judge Vernon Broderick: ‘He accepted responsibility for his crimes, he has demonstrated sincere remorse. There is no excuse for the conduct. He doesn’t make any excuses for the conduct,” reports Hayes.
At the community meeting in Florida Hayes said Collins “used his opening remarks to emphasize (again and again) his coziness with Trump, [but] he left out the best evidence of their close relationship: Trump pardoned Collins after his guilty pleas and let him out of prison just two months into a two-year sentence.
But being an ally of Trump is what really matters in this deep-red Trump district, said Hayes. In fact, of all the candidates (and there are many more than Cawthorne and Collins) the only candidate whose website didn’t lead with Trump is Jim Oberweis, said Hayes. But of course his campaign—like all the others—is “nudging the White House political team for a Trump endorsement.
Every candidate is allied on policy, so the only advantage is which one gets the presidential nod, said Hayes.
“Nobody’s really campaigning — except to campaign to Trump,” said Francis Rooney, the former representative for the district. “The idea of Trump, the impact of Trump and MAGA is so overwhelming right now that the people want to be in that tent. And so they’re focusing on the things that are going to get the attention of the MAGA leadership.”
---
---}:
AN 3 26
Moments before President Donald Trump announced that talks with Iran were going well and that he would not make good on his threat to bomb one of their civilian power plants, someone dropped about $580 million in the oil futures market.
"In one move, $1.5 billion in S&P 500 futures were purchased. This trade was so large it sent the entire index +0.3 percent higher that minute," the independent news site Europa posted on X. "$192 million in oil futures were also sold."
It happened five minutes before Trump posted on Truth Social, saying he was de-escalating the situation in Iran.
Professor Adam Cochran pointed out that it was "more than 4x-6x any other trade size during the market close ... Insiders profited from his lies in broad daylight!"
The sell-off is also sparking further questions about huge bets on Polymarket, which allows people to bet on whether something will happen.
In January, a new user on Polymarket suddenly popped up with a huge investment, betting that Venezuelan President Nicolás Maduro would be ousted. It happened mere hours before he was taken by U.S. forces.
CNN reported on Tuesday that at least one person on Polymarket has made nearly $1 million since 2024 after a number of remarkably accurate and well-timed bets about military actions against Iran, an analyst shared.
"The bettor won a staggering 93 percent of their five-figure wagers about Iran, even though the events they predicted were unannounced military operations," the report said.
To put that in context, Todd Phillips, a finance professor at Georgia State University, told CNN that most high-frequency traders have a win rate closer to 50 percent.
"The Bubblemaps analysis showed that the Iran trader had an overall win rate of 83 percent, and a 93 percent rate for trades over $10,000. They netted nearly $967,000," CNN said.
“It sure seems like this person either has incredible luck, or was insider trading,” Phillips said. “Having win rates in the 80 percent to 90 percent range is just too good to be true. I look at this, and I think something fishy is going on.”
The better also won cash on a bet "hours before Israeli strikes in October 2024 during its tit-for-tat conflict with Iran, hours before US airstrikes against Iranian nuclear facilities in June 2025" and just hours before the surprise attack in February.
"There's some clear, potential signs of insider activity," reporter Marshall Cohen told Dana Bash on "Inside Politics" on Tuesday. "There could be an honest, reasonable explanation. We just don't know."
“All of this is strong signaling of insider activity, based on the amount they made, the markets they bet on, the timing of their trades, the success rates of these trades and the fact that they are connected on-chain,” Bubblemaps CEO Nick Vaiman told CNN about the trader. “This is pretty suspicious in my book.”
Kalshi, another site that allows betting like Polymarket, is in the U.S., so it must abide by U.S. insider trading laws. But Polymarket is headquartered overseas and doesn't have to abide by the same rules.
None of these prediction markets are regulated because they're so new and the law hasn't caught up with the technology yet.
On Monday, Polymarket announced new rules for offshore and US-based platforms, to “clarify three core categories of prohibited insider trading conduct.”
Essentially, the company's solution is to have users agree not to commit insider trading. They also put a page up on their website that explains what insider trading is.
"They banned trades based on information that users were legally required to keep confidential, and trades based on tips from someone with the same obligation," said CNN's report.
Polymarket said that people in “a position of authority or influence” over a major global event cannot bet on markets that are involved in those issues. The new regulations would mean that any inside information the families of those individuals also cannot be traded on.
---
---
an 4 25
'Could be an enormous scam': Insider trading suspicions grow after Trump tariff pause
---
===
an 4 24
a Russian businessman based in South Florida may have made millions off of insider trading in a scheme involving the parent company of former President Donald Trump's Truth Social platform.
The Miami Herald reported Wednesday that investor Anton Postolnikov — the nephew of a former staffer to Russian President Vladimir Putin — is mentioned in court documents from a 2023 New York securities fraud case prosecutors brought against three men from South Florida. Gerald and Michael Shvartsman, along with accomplice Bruce Garelick, allegedly pocketed $23 million from insider trading involving a 2021 merger between Trump Media and Technology Group and the Miami, Florida-based Digital World Acquisition Corp.
Garelick and the Shvartsman brothers are accused of sharing non-public information with friends and colleagues in order to maximize their gains from the deal. Documents show Postolnikov loaned $8 million to Trump's company through a Caribbean bank he owns that frequently works with the pornography industry.
While neither Trump nor Postolnikov are facing any allegations of wrongdoing from the deal, the Herald reported that prosecutors could tack on more charges in a subsequent indictment. However, it remains unclear if Postolnikov will be added as an additional defendant. A separate filing by Tai Park — the defense attorney representing Michael Shvartsman — suggests that his client could face new charges of money laundering in response to his efforts to conceal his alleged insider trading profits.
Meanwhile, Garelick, who sat on the board of Digital World Acquisition Corp, is accused of making $50,000 from the merger in his work for Shvartsman's company, Rocket One Capital. Digital World is a special purpose acquisition company, or SPAC, which is often used as a vehicle for entities seeking to become publicly traded companies, as it involves less regulatory oversight than a traditional initial public offering (IPO). The Herald reported that months before the merger was announced, Garelick wrote a message to Postolnikov that read "Anton, Good times last night! Following up on that Trump Media Group SPAC we mentioned. The deal is going to finalize this week. Please let us know if you are interested in investing."
The murky details of the merger may be partially why the deal has yet to be approved by the US Securities and Exchange Commission after being on hold for more than two years. As a result of that delay, Trump Media and Technology Group has bled approximately $1 billion in investment commitments as of fall 2023. in the first three quarters of 2023, the company only posted $3.4 million in total revenue, which is far behind competing social media companies like Facebook and X/Twitter.
University of Florida business professor Jay Ritter — an expert on publicly traded companies — told the Herald that the fact that the merger is still on hold is "pretty unprecedented." He also likened the SPAC's performance to a "meme stock," in which social media sentiment drives a stock's performance more than other traditional business metrics.
READ MORE:[Russian sources vanished after Trump declassified Christopher Steele material: report
Click here to read the Herald's full report.
===
an 4 24
Two investors who were involved in the merger that helped make the parent company of former President Donald Trump's social media platform go public are now convicted felons after entering a guilty plea on Wednesday.
CNN reported that brothers Gerald and Michael Shvartsman each pleaded guilty to one count apiece of securities fraud in relation to an insider trading case first brought against them in June of 2023. The South Florida-based investors pocked more than $22 million after tipping off friends and family about the merger that would bring about the initial public offering (IPO) of Trump Media and Technology Group (TMTG).
The IPO came about after a special purpose acquisition group — more commonly known as a SPAC — dubbed "Digital World Acquisition Group" (DWAC) agreed to buy TMTG and take it public in March. The Shvartsman brothers and a third associate, Bruce Garelick knew about the SPAC's plans well ahead of time and invited their associates in 2021 to invest in the company before the news became public. The knowledge likely came from Garelick, who at the time was on the board of the SPAC. Investors then reaped a significant windfall after the merger plans and eventual IPO were announced.
READ MORE:Putin-connected businessman loaned $8M to Trump entity involved in alleged insider trading
"Michael and Gerald Shvartsman admitted in court that they received confidential, inside information about an upcoming merger between DWAC and Trump Media and used that information to make profitable, but illegal, open-market trades," US Attorney for the Southern District of New York Damien Williams said in a public statement.
“Insider trading is cheating, plain and simple,” he continued, adding that the guilty plea "should remind anyone who may be tempted to corrupt the integrity of the stock market that it will earn them a ticket to prison.”
TMTG went public last week, trading for nearly $70 per share on the Nasdaq Composite as $DJT. However, after a filing with financial regulators showed that Truth Social suffered more than $50 million in losses last year and needed the SPAC's funding to remain operational, investors immediately soured on the stock, causing it to plummet in value by roughly $4 billion in its first week of trading. As Trump is the majority shareholder, he lost approximately $1 billion in personal net worth due to the stock's poor performance.
Following the disastrous first week after his IPO, the former president sued his business partners, Andy Litinsky and Wes Moss, in Florida court. Trump accusing them of mishandling the setup of the company's corporate governance structure and botching the merger with DWAC.
READ MORE:Trump sues his Truth Social business partners after stock loses $4 billion in first week of trading
Trump's suit came about after Litinsky and Moss filed their own suit against the ex-president in Delaware Chancery Court. In that complaint, the two investors said Trump engaged in "11th hour, pre-merger corporate maneuvering" to "drastically dilute" the value of their 8.6% stake in the company.
The former president, who has 78 million shares in TMTG, allegedly tried to artificially inflate the number of shares to one billion, which would have reduced Litinsky and Moss' stake to less than 1% of TMTG. Their attorney, Christopher J. Clark, told the Washington Post at the time that Trump was "baselessly trying to renege" on a prior agreement.
While Trump stood to gain more than $3.5 billion from the IPO, he is prohibited from selling any of his shares until after the company has been public for at least six months. If the stock continues to decline in value, his shares may be close to worthless by the time he's able to sell.
READ MORE:['No legitimate business purpose': Trump sued by Truth Social business partners
Here's what federal law says about Trump 'threatening a sitting president': ex-federal prosecutor](https://www.alternet.org/trump-biden-violence/ "Here's what federal law says about Trump 'threatening a sitting president': ex-federal prosecutor")
===
---
an 12 23
in a September 2020 report, the House Transportation Committee found that Boeing and the Federal Aviation Administration (FAA) "played instrumental and causative roles" in two deadly plane crashes that, combined, killed 346 people altogether.
Before that, according to Daily Beast reporters Roger Sollenberger and Riley Rogerson, Rep. Mike Garcia (R-California) "sold up to $50,000 in" Boeing shares. That August 2020 sale, the journalists report in an article published on December 13, came "weeks before" the "damning results of" a congressional probe "into deadly crashes involving the company's 737 Max airliner" became public.
"But while other incumbent campaigns were dogged by blockbuster stock scandals that year," Sollenberger and Rogerson report, "the Garcia campaign never had to answer for this trade. That's because Garcia blew the mandated deadline to report the transaction, only filing the paperwork on November 23 — more than two months after the 45-day reporting window had closed."
The Beast reporters continue, "When he finally did disclose the sale, it was two weeks after the 2020 general election votes were cast, and three days after Garcia declared victory. He won by 333 votes."
In a once-red state that has become increasingly Democratic in recent decades, Garcia has defeated Democrat Christy Smith (who formerly served in the California State Assembly) three times — first in a special election in May 2020, then in the general elections of 2020 and 2022.
The Daily Beast interviewed some legal experts, who, according to Sollenberger and Rogerson, described the delay as an "egregious" ethics violation.
The Campaign Legal Center's Delaney Marsco told the Beast, "When members file late, this is the cost: It deprives voters of the information to assess it themselves."
READ MORE:Dems hit swing district House Republicans for supporting Mike Johnson’s far-right wish list
Citizens for Responsibility and Ethics in Washington (CREW) Communications Director Jordan Libowitz told the Beast that Garcia failed to report the trade "at a time when people would have been asking questions about it" — adding, "There’s a chance he's in Congress today because he hid this. And it raises the question of whether he's looking out for his constituents or is he just trying to enrich himself."
READ MORE:House Freedom Caucus blasts Mike Johnson’s spending plan: 'Not a single meaningful win'
*Read The Daily Beast's full report at this link (subscription required).
---
Marijuana Opportunity Reinvestment & Expungement Act (MORE) conflict of interest
In December 2020, Foxx voted against the Marijuana Opportunity Reinvestment & Expungement Act (MORE).[52] According to financial disclosure reports, she made at least six investments inAltria,one of the world's largest tobacco companies and a leader in the burgeoning U.S. cannabis industry, since September 2020.[53] In all, records show she has purchased somewhere between $79,000 and $210,000 in Altria stock.[54]^
---
https://www.alternet.org/2022/02/stock-trading/
MOC
---
an 2/22
amid push for ban, Lawmakers traded $355 million of stock in 2021
As the coronavirus pandemic continued to roil the U.S. economy and take lives in 2021, congressional lawmakers and their family members went on a stock buying and selling...
---
---
https://www.alternet.org/2020/08/heres-how-american-billionaires-have-profiteered-off-the-robert-reich/
==
Several U.S. ambassadors actively shed their stock holdings as President Donald Trump tried to downplay the coronavirus outbreak in its early stages,” according to CNBC.
Ambassadors to Uruguay, France, Morocco and Italy sold shares in transactions that could have made them millions of dollars, according to financial disclosure filings reviewed by CNBC. Much of their sales were in January and continued throughout February, the records show. Their transactions line up with a timeline of federal and congressional announcements as the virus started sweeping across the globe earlier this year.
---
https://www.propublica.org/article/senator-dumped-up-to-1-6-million-of-stock-after-reassuring-public-about-coronavirus-preparedness
---
https://www.alternet.org/2020/01/are-trump-and-his-ilk-manipulating-the-markets-for-personal-gain-investigative-business-reporter-william-cohan-lays-out-the-evidence/